Jefferies reiterated its Buy rating but lowered its price target on AP Pharma (OTC: APPA) from $1.50 to $1.25 after ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE